Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank71
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-49.27M
↑ 73% vs avg
Percentile
P71
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-184.70M
Historical baseline
PeriodValueYoY Change
TTM$-49.27M+84.6%
2024$-320.51M+14.8%
2023$-376.11M-13.6%
2022$-331.15M-52.7%
2021$-216.88M-14.9%
2020$-188.79M-28.9%
2019$-146.45M-43.8%
2018$-101.87M-74.5%
2017$-58.36M-1.4%
2016$-57.58M-